Heartflow Business Summary

HeartFlow, Inc. (Nasdaq: HTFL) is a commercial-stage medical technology leader specializing in AI-driven, non-invasive cardiac diagnostics. The company primarily generates revenue through a cloud-based, transactional SaaS model, charging healthcare providers per-case fees for its flagship HeartFlow FFRct Analysis, which currently accounts for the vast majority of its total revenue. Its business segments are centered on coronary artery disease (CAD) management, utilizing deep learning algorithms to transform standard coronary CT scans into personalized 3D models that quantify blood flow and arterial plaque. HeartFlow competes with specialized AI firms such as Cleerly and CathWorks, as well as major medical imaging OEMs including Siemens Healthineers, GE HealthCare, and Philips. Within this competitive landscape, HeartFlow maintains a dominant market position as the most clinically validated provider of non-invasive fractional flow reserve technology, supported by extensive global reimbursement coverage and an expanding product suite that includes the HeartFlow ONE platform and PCI Navigator. The company was co-founded by Dr. Charles Taylor, a former Stanford professor who pioneered the application of computational fluid dynamics to human blood flow, and Dr. Christopher Zarins, a renowned vascular surgeon. The executive leadership team is led by President and CEO John Farquhar, a Medtronic veteran with over 20 years of experience in cardiovascular and diabetes technology. Other critical leaders include Chief Financial Officer Vikram Verghese, who brings a background from Verily and Medtronic, and Chief Technology Officer Tim Fonte, who oversees the advancement of the company’s AI-driven insights. HeartFlow’s strategic direction is further guided by Chairman of the Board William Weldon, the former Chairman and CEO of Johnson & Johnson. The company is backed by a high-profile roster of institutional investors, including Bain Capital Life Sciences, Baillie Gifford, and Capricorn Investment Group, reflecting its strong pedigree at the intersection of healthcare and high-performance computing.